Antonio Morales-Hernández
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Antonio Morales-Hernández has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Shannon McKinney-Freeman
Department of Hematology, St. Jude Children’s Research Hospital, Memphis, TN, USA
3 shared publications Alanna V. Van Huizen
Department of Hematology, St. Jude Children’s Research Hospital, Memphis, TN, USA
1 shared publicationAshley Chabot
Department of Hematology St. Jude Children's Research Hospital Memphis Tennessee USA
1 shared publication- Chaithanyarani Parupalli
Department of Hematology, St. Jude Children’s Research Hospital, Memphis, TN
1 shared publication Claiborne Christian
Department of Hematology, St. Jude Children’s Research Hospital, Memphis, TN
1 shared publicationClaire Caprio
Department of Hematology St. Jude Children's Research Hospital Memphis Tennessee USA
1 shared publication
Latest Publications
- Open Access
Elevated endocytic trafficking mediated by GPRASP2 maintains HSC fidelity
Endolysosomal trafficking supports cellular homeostasis through coordinated regulation of extrinsic signaling inputs. Hematopoietic stem cell (HSC) function requires a tightly regulated balance between quiescence for long-term preservation and rapid activation for blood production. Although lysosomal regulation of metabolism and quiescence has been linked to stem cell maintenance, the contribution of endocytic routing to lysosomal function remains incompletely understood. Here, we show that quiescent HSCs rely on elevated endocytosis to maintain self-renewal. This activity is mediated in part by GPRASP2, a post-endosomal sorting protein. HSCs enriched in GPRASP2 are functionally dormant yet molecularly primed for activation however, in response to proliferative cues, dormant HSCs exhibit reduced signaling and proliferation. Disruption of GPRASP2-mediated endocytosis induces rapid proliferation and increased expression of signaling constituents, consistent with a model in which elevated endocytosis attenuates signaling through receptor internalization. Thus, we identify endocytosis as a mechanism by which HSCs limit functional exhaustion arising from chronic activation.
Open AccessElevated endocytic trafficking mediated by GPRASP2 maintains HSC fidelity
Endolysosomal trafficking supports cellular homeostasis through coordinated regulation of extrinsic signaling inputs. Hematopoietic stem cell (HSC) function requires a tightly regulated balance between quiescence for long-term preservation and rapid activation for blood production. Although lysosomal regulation of metabolism and quiescence has been linked to stem cell maintenance, the contribution of endocytic routing to lysosomal function remains incompletely understood. Here, we show that quiescent HSCs rely on elevated endocytosis to maintain self-renewal. This activity is mediated in part by GPRASP2, a post-endosomal sorting protein. HSCs enriched in GPRASP2 are functionally dormant yet molecularly primed for activation however, in response to proliferative cues, dormant HSCs exhibit reduced signaling and proliferation. Disruption of GPRASP2-mediated endocytosis induces rapid proliferation and increased expression of signaling constituents, consistent with a model in which elevated endocytosis attenuates signaling through receptor internalization. Thus, we identify endocytosis as a mechanism by which HSCs limit functional exhaustion arising from chronic activation.
- Open Access
- 30 October 2024
- Published by Wiley in HemaSphere
- Vol. 8 (11) , e70037
GPRASP protein deficiency triggers lymphoproliferative disease by affecting B‐cell differentiation
Gprasp1 and Gprasp2 encode proteins that control the stability and cellular trafficking of CXCR4, a master regulator of hematopoiesis whose dynamic regulation is required for appropriate trafficking of B‐cells in the germinal center (GC). Here, we report that Gprasp1 and Gprasp2‐deficient B‐cells accumulate in the GC and show transcriptional abnormalities, affecting the mechanisms controlling Aicda expression and exposing them to excessive somatic hypermutation. Consequently, about 30% of mice transplanted with Gprasp‐deficient hematopoietic stem and progenitor cells developed a biologically aggressive and fatal B‐cell hyperproliferative disease by 20–50 weeks posttransplant. Histological and molecular profiling reveal that Gprasp1‐ and Gprasp2‐deficient neoplasms morphologically resemble human high‐grade B‐cell lymphomas of germinal center origin with shared morphologic features of both Burkitt Lymphoma (BL) and diffuse large B‐cell lymphoma (DLBCL), and molecular features consistent with DLBCL, as well as elevated mutational burden and heterogenous transcriptional and mutational signature. Thus, reduced Gprasp1 and Gprasp2 gene expression perturbs B‐cell maturation and increases the risk of B‐cell neoplasms of germinal center origin. As this model recapitulates the essential features of the heterogenous group of human hematopoietic malignancies, it could be a powerful tool to interrogate the mechanisms of lymphomagenesis for these cancers.
- 30 October 2024
- Published by Wiley in HemaSphere
- Vol. 8 (11) , e70037
Open AccessGPRASP protein deficiency triggers lymphoproliferative disease by affecting B‐cell differentiation
Gprasp1 and Gprasp2 encode proteins that control the stability and cellular trafficking of CXCR4, a master regulator of hematopoiesis whose dynamic regulation is required for appropriate trafficking of B‐cells in the germinal center (GC). Here, we report that Gprasp1 and Gprasp2‐deficient B‐cells accumulate in the GC and show transcriptional abnormalities, affecting the mechanisms controlling Aicda expression and exposing them to excessive somatic hypermutation. Consequently, about 30% of mice transplanted with Gprasp‐deficient hematopoietic stem and progenitor cells developed a biologically aggressive and fatal B‐cell hyperproliferative disease by 20–50 weeks posttransplant. Histological and molecular profiling reveal that Gprasp1‐ and Gprasp2‐deficient neoplasms morphologically resemble human high‐grade B‐cell lymphomas of germinal center origin with shared morphologic features of both Burkitt Lymphoma (BL) and diffuse large B‐cell lymphoma (DLBCL), and molecular features consistent with DLBCL, as well as elevated mutational burden and heterogenous transcriptional and mutational signature. Thus, reduced Gprasp1 and Gprasp2 gene expression perturbs B‐cell maturation and increases the risk of B‐cell neoplasms of germinal center origin. As this model recapitulates the essential features of the heterogenous group of human hematopoietic malignancies, it could be a powerful tool to interrogate the mechanisms of lymphomagenesis for these cancers.
- Open Access
- 9 May 2024
- Published by American Society of Hematology in Blood
- Vol. 143 (19) , 1883-1884
Patrolling progenitors: a first responder team
In this issue of Blood, Quaranta et al identify human circulating hematopoietic stem and progenitor cells (cHSPCs) that help maintain steady-state hematopo In this issue of Blood, Quaranta et al identify human circulating hematopoietic stem and progenitor cells (cHSPCs) that help maintain steady-state hematopo
- 9 May 2024
- Published by American Society of Hematology in Blood
- Vol. 143 (19) , 1883-1884
Open AccessPatrolling progenitors: a first responder team
In this issue of Blood, Quaranta et al identify human circulating hematopoietic stem and progenitor cells (cHSPCs) that help maintain steady-state hematopo In this issue of Blood, Quaranta et al identify human circulating hematopoietic stem and progenitor cells (cHSPCs) that help maintain steady-state hematopo
- Open Access
- 23 August 2023
- Published by American Society of Hematology in Blood Advances
- Vol. 7 (17) , 4677-4689
An NFIX-mediated regulatory network governs the balance of hematopoietic stem and progenitor cells during hematopoiesis
The transcription factor (TF) nuclear factor I-X (NFIX) is a positive regulator of hematopoietic stem and progenitor cell (HSPC) transplantation. Nfix-deficient HSPCs exhibit a severe loss of repopulating activity, increased apoptosis, and a loss of colony-forming potential. However, the underlying mechanism remains elusive. Here, we performed cellular indexing of transcriptomes and epitopes by high-throughput sequencing (CITE-seq) on Nfix-deficient HSPCs and observed a loss of long-term hematopoietic stem cells and an accumulation of megakaryocyte and myelo-erythroid progenitors. The genome-wide binding profile of NFIX in primitive murine hematopoietic cells revealed its colocalization with other hematopoietic TFs, such as PU.1. We confirmed the physical interaction between NFIX and PU.1 and demonstrated that the 2 TFs co-occupy super-enhancers and regulate genes implicated in cellular respiration and hematopoietic differentiation. In addition, we provide evidence suggesting that the absence of NFIX negatively affects PU.1 binding at some genomic loci. Our data support a model in which NFIX collaborates with PU.1 at super-enhancers to promote the differentiation and homeostatic balance of hematopoietic progenitors.
- 23 August 2023
- Published by American Society of Hematology in Blood Advances
- Vol. 7 (17) , 4677-4689
Open AccessAn NFIX-mediated regulatory network governs the balance of hematopoietic stem and progenitor cells during hematopoiesis
The transcription factor (TF) nuclear factor I-X (NFIX) is a positive regulator of hematopoietic stem and progenitor cell (HSPC) transplantation. Nfix-deficient HSPCs exhibit a severe loss of repopulating activity, increased apoptosis, and a loss of colony-forming potential. However, the underlying mechanism remains elusive. Here, we performed cellular indexing of transcriptomes and epitopes by high-throughput sequencing (CITE-seq) on Nfix-deficient HSPCs and observed a loss of long-term hematopoietic stem cells and an accumulation of megakaryocyte and myelo-erythroid progenitors. The genome-wide binding profile of NFIX in primitive murine hematopoietic cells revealed its colocalization with other hematopoietic TFs, such as PU.1. We confirmed the physical interaction between NFIX and PU.1 and demonstrated that the 2 TFs co-occupy super-enhancers and regulate genes implicated in cellular respiration and hematopoietic differentiation. In addition, we provide evidence suggesting that the absence of NFIX negatively affects PU.1 binding at some genomic loci. Our data support a model in which NFIX collaborates with PU.1 at super-enhancers to promote the differentiation and homeostatic balance of hematopoietic progenitors.
- 1 September 2016
- Published by Elsevier in NeuroToxicology
- Vol. 56, 55-63
AhR-dependent 2,3,7,8-tetrachlorodibenzo- p -dioxin toxicity in human neuronal cell line SHSY5Y
- 1 September 2016
- Published by Elsevier in NeuroToxicology
- Vol. 56, 55-63
AhR-dependent 2,3,7,8-tetrachlorodibenzo- p -dioxin toxicity in human neuronal cell line SHSY5Y